DiaMedica Therapeutics Statistics

Total Valuation

DMAC has a market cap or net worth of $335.15 million. The enterprise value is $275.50 million.

Market Cap	335.15M
Enterprise Value	275.50M

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026, after market close.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

DMAC has 53.88 million shares outstanding. The number of shares has increased by 16.28% in one year.

Current Share Class	53.88M
Shares Outstanding	53.88M
Shares Change (YoY)	+16.28%
Shares Change (QoQ)	+5.62%
Owned by Insiders (%)	47.24%
Owned by Institutions (%)	24.50%
Float	28.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	5.96
P/TBV Ratio	5.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.81, with a Debt / Equity ratio of 0.00.

Current Ratio	11.81
Quick Ratio	11.72
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -67.68% and return on invested capital (ROIC) is -44.14%.

Return on Equity (ROE)	-67.68%
Return on Assets (ROA)	-39.92%
Return on Invested Capital (ROIC)	-44.14%
Return on Capital Employed (ROCE)	-61.16%
Weighted Average Cost of Capital (WACC)	10.58%
Revenue Per Employee	n/a
Profits Per Employee	-$936,171
Employee Count	35
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, DMAC has paid $28,000 in taxes.

Income Tax	28,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +53.96% in the last 52 weeks. The beta is 1.15, so DMAC's price volatility has been higher than the market average.

Beta (5Y)	1.15
52-Week Price Change	+53.96%
50-Day Moving Average	7.15
200-Day Moving Average	7.01
Relative Strength Index (RSI)	39.48
Average Volume (20 Days)	181,174

Short Selling Information

The latest short interest is 4.77 million, so 8.86% of the outstanding shares have been sold short.

Short Interest	4.77M
Short Previous Month	4.59M
Short % of Shares Out	8.86%
Short % of Float	16.79%
Short Ratio (days to cover)	20.40

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-34.40M
Pretax Income	-32.74M
Net Income	-32.77M
EBITDA	-34.35M
EBIT	-34.40M
Earnings Per Share (EPS)	-$0.70

Full Income Statement

Balance Sheet

The company has $59.89 million in cash and $240,000 in debt, giving a net cash position of $59.65 million or $1.11 per share.

Cash & Cash Equivalents	59.89M
Total Debt	240,000
Net Cash	59.65M
Net Cash Per Share	$1.11
Equity (Book Value)	56.11M
Book Value Per Share	1.04
Working Capital	55.50M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$29.06 million and capital expenditures -$40,000, giving a free cash flow of -$29.10 million.

Operating Cash Flow	-29.06M
Capital Expenditures	-40,000
Depreciation & Amortization	43,000
Net Borrowing	-10,000
Free Cash Flow	-29.10M
FCF Per Share	-$0.54

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DMAC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.28%
Shareholder Yield	-16.28%
Earnings Yield	-9.78%
FCF Yield	-8.68%

Analyst Forecast

The average price target for DMAC is $15.50, which is 149.20% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.50
Price Target Difference	149.20%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 15, 2018. It was a reverse split with a ratio of 1:20.

Last Split Date	Nov 15, 2018
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	2